Literature DB >> 19070386

Outcome after wait-listing for emergency liver transplantation in acute liver failure: a single centre experience.

William Bernal1, Timothy J S Cross, Georg Auzinger, Elizabeth Sizer, Michael A Heneghan, Matthew Bowles, Paulo Muiesan, Mohammed Rela, Nigel Heaton, Julia Wendon, John G O'Grady.   

Abstract

BACKGROUND/AIMS: Though emergency liver transplantation (ELT) is an established treatment for severe acute liver failure (ALF), outcomes are inferior to elective surgery. Despite prioritization, many patients deteriorate, becoming unsuitable for ELT.
METHODS: We examined a single-centre experience of 310 adult patients with ALF registered for ELT over a 10-year period to determine factors associated with failure to transplant, and in those patients undergoing ELT, those associated with 90-day mortality.
RESULTS: One hundred and thirty-two (43%) patients had ALF resulting from paracetamol and 178 (57%) from non-paracetamol causes. Seventy-four patients (24%) did not undergo surgery; 92% of these died. Failure to transplant was more likely in patients requiring vasopressors at listing (hazard ratio 1.9 (95% CI 1.1-3.6)) paracetamol aetiology (2.5 (1.4-4.6)) but less likely in blood group A (0.5 (0.3-0.9)). Post-ELT survival at 90-days and one-year increased from 66% and 63% in 1994-1999 to 81% and 79% in 2000-2004 (p<0.01). Four variables were associated with post-ELT mortality; age >45 years (3 (1.7-5.3)), vasopressor requirement (2.2 (1.3-3.8), transplantation before 2000 (1.9 (1.1-3.3)) and use of high-risk grafts (2.3 (1.3-4.2).
CONCLUSIONS: The data indicate improved outcomes in the later era, despite higher level patient dependency and greater use of high-risk grafts, through improved graft/recipient matching.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19070386     DOI: 10.1016/j.jhep.2008.09.012

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  33 in total

1.  Amyloidosis and subacute liver failure.

Authors:  Moby Joseph; Timothy J S Cross
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-03

2.  Outcome of acute liver failure in the elderly.

Authors:  Frank V Schiødt; Raymond T Chung; Michael L Schilsky; J Eileen Hay; Erik Christensen; William M Lee
Journal:  Liver Transpl       Date:  2009-11       Impact factor: 5.799

Review 3.  Liver transplantation in acute-on-chronic liver failure: lessons learnt from acute liver failure setting.

Authors:  Mettu Srinivas Reddy; Rajesh Rajalingam; Mohamed Rela
Journal:  Hepatol Int       Date:  2015-01-08       Impact factor: 6.047

Review 4.  Acute liver failure and liver transplantation.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara; Norihiro Kokudo
Journal:  Intractable Rare Dis Res       Date:  2013-08

Review 5.  Acute liver failure: a life-threatening disease.

Authors:  Ali Canbay; Frank Tacke; Johannes Hadem; Christian Trautwein; Guido Gerken; Michael P Manns
Journal:  Dtsch Arztebl Int       Date:  2011-10-21       Impact factor: 5.594

6.  Proteomic Signature of Acute Liver Failure: From Discovery and Verification in a Pig Model to Confirmation in Humans.

Authors:  Jie Wang; Zeyu Sun; Jing Jiang; Daxian Wu; Xiaoli Liu; Zhongyang Xie; Ermei Chen; Danhua Zhu; Chao Ye; Xiaoqian Zhang; Wenqian Chen; Hongcui Cao; Lanjuan Li
Journal:  Mol Cell Proteomics       Date:  2017-03-23       Impact factor: 5.911

7.  Determinants of outcome among patients with acute liver failure listed for liver transplantation in the United States.

Authors:  K Rajender Reddy; Caitlyn Ellerbe; Michael Schilsky; R Todd Stravitz; Robert J Fontana; Valerie Durkalski; William M Lee
Journal:  Liver Transpl       Date:  2016-04       Impact factor: 5.799

8.  Aetiology and outcome of acute liver failure.

Authors:  Ravi Marudanayagam; Vivekanandan Shanmugam; Bridget Gunson; Darius F Mirza; David Mayer; John Buckels; Simon R Bramhall
Journal:  HPB (Oxford)       Date:  2009-08       Impact factor: 3.647

Review 9.  Novel acetylcysteine regimens for treatment of paracetamol overdose.

Authors:  W Stephen Waring
Journal:  Ther Adv Drug Saf       Date:  2012-12

10.  Two-year outcomes in initial survivors with acute liver failure: results from a prospective, multicentre study.

Authors:  Robert J Fontana; Caitlyn Ellerbe; Valerie E Durkalski; Amol Rangnekar; Rajender K Reddy; Todd Stravitz; Brendan McGuire; Timothy Davern; Adrian Reuben; Iris Liou; Oren Fix; Daniel R Ganger; Raymond T Chung; Mike Schilsky; Steven Han; Linda S Hynan; Corron Sanders; William M Lee
Journal:  Liver Int       Date:  2014-07-28       Impact factor: 5.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.